Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Adjuvant Oxyhydrogen Therapy for Severe COPD
NCT02850185Unknown
- Sponsor
- Asclepius Meditec
- Start
- Jul 2016
- Primary completion
- Jul 2020
- Countries
- 1
01
Overview
Randomised, double-blind trial in chronic obstructive pulmonary disease (COPD) (2 arms), sponsored by Asclepius Meditec. Primary endpoint: Modified Medical Research Council Dyspnea Scale at 3 months. Status: unknown.
02
Conditions
chronic obstructive pulmonary disease (COPD)
Beyond the preview
Go deeper on NCT02850185.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02850185.